Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predicting Prostate Cancer Progression as a Function of ETS-related Gene Status, Race, and Obesity in a Longitudinal Patient Cohort.
Cullen J, Young D, Chen Y, Degon M, Farrell J, Sedarsky J, Baptiste W, Rosen P, Tolstikov V, Kiebish M, Kagan J, Srivastava S, Kuo HC, Moncur JT, Rosner IL, Narain N, Akmaev V, Petrovics G, Dobi A, McLeod DG, Srivastava S, Sesterhenn IA. Cullen J, et al. Among authors: tolstikov v. Eur Urol Focus. 2018 Dec;4(6):818-824. doi: 10.1016/j.euf.2017.02.016. Epub 2017 Mar 11. Eur Urol Focus. 2018. PMID: 28753864 Free PMC article.
Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer.
Kiebish MA, Cullen J, Mishra P, Ali A, Milliman E, Rodrigues LO, Chen EY, Tolstikov V, Zhang L, Panagopoulos K, Shah P, Chen Y, Petrovics G, Rosner IL, Sesterhenn IA, McLeod DG, Granger E, Sarangarajan R, Akmaev V, Srinivasan A, Srivastava S, Narain NR, Dobi A. Kiebish MA, et al. Among authors: tolstikov v. J Transl Med. 2020 Jan 7;18(1):10. doi: 10.1186/s12967-019-02185-y. J Transl Med. 2020. PMID: 31910880 Free PMC article.
Metabolomic effects of androgen deprivation therapy treatment for prostate cancer.
Chi JT, Lin PH, Tolstikov V, Oyekunle T, Chen EY, Bussberg V, Greenwood B, Sarangarajan R, Narain NR, Kiebish MA, Freedland SJ. Chi JT, et al. Among authors: tolstikov v. Cancer Med. 2020 Jun;9(11):3691-3702. doi: 10.1002/cam4.3016. Epub 2020 Mar 31. Cancer Med. 2020. PMID: 32232974 Free PMC article. Clinical Trial.
Serum metabolomic analysis of men on a low-carbohydrate diet for biochemically recurrent prostate cancer reveals the potential role of ketogenesis to slow tumor growth: a secondary analysis of the CAPS2 diet trial.
Chi JT, Lin PH, Tolstikov V, Howard L, Chen EY, Bussberg V, Greenwood B, Narain NR, Kiebish MA, Freedland SJ. Chi JT, et al. Among authors: tolstikov v. Prostate Cancer Prostatic Dis. 2022 Apr;25(4):770-777. doi: 10.1038/s41391-022-00525-6. Epub 2022 Mar 25. Prostate Cancer Prostatic Dis. 2022. PMID: 35338353 Clinical Trial.
The influence of low-carbohydrate diets on the metabolic response to androgen-deprivation therapy in prostate cancer.
Chi JT, Lin PH, Tolstikov V, Oyekunle T, Alvarado GCG, Ramirez-Torres A, Chen EY, Bussberg V, Chi B, Greenwood B, Sarangarajan R, Narain NR, Kiebish MA, Freedland SJ. Chi JT, et al. Among authors: tolstikov v. Prostate. 2021 Jul;81(10):618-628. doi: 10.1002/pros.24136. Epub 2021 May 5. Prostate. 2021. PMID: 33949711 Free PMC article. Clinical Trial.
65 results